Team:ETH Zurich/Modeling/Overview
From 2008.igem.org
Luca.Gerosa (Talk | contribs) |
Luca.Gerosa (Talk | contribs) |
||
Line 45: | Line 45: | ||
* Is it possible to slow growth of large genome strains by using a thymidine autroxophic strain and limiting thymidine feeding? | * Is it possible to slow growth of large genome strains by using a thymidine autroxophic strain and limiting thymidine feeding? | ||
* What is the best restriction enzyme to be used in order to maximize genome reduction and at the same time vitality (growth rate) of thymidine autroxophic strains? | * What is the best restriction enzyme to be used in order to maximize genome reduction and at the same time vitality (growth rate) of thymidine autroxophic strains? | ||
- | * Which are the | + | * Which are the predicted quantitative differences in terms of growth rate and genome size of strains on which has been applied the selection procedure? |
<br><br> | <br><br> | ||
'''Method:''' <br> | '''Method:''' <br> |
Revision as of 15:56, 11 October 2008
Overview on the modelling frameworkThis page is meant to give an introduction to the the overall modelling framework we have constructed in order to asses feasibility analysis, temporal scale details and other parameter estimations that regard our project setup. As introduced in the project overview section, four main components can be identified in the deviced mechanism. Accordingly, we divided the modelling framework in four modules that tackles the relative problematics.
|